158 related articles for article (PubMed ID: 37666696)
1. Factors associated with intention for revaccination among patients with adverse events following immunization.
Muñoz CE; Pham-Huy A; Pernica JM; Boucher FD; De Serres G; Vaudry W; Constantinescu C; Sadarangani M; Bettinger JA; Tapiéro B; Morris SK; McConnell A; Noya F; Halperin SA; Top KA;
Vaccine; 2023 Oct; 41(42):6239-6247. PubMed ID: 37666696
[TBL] [Abstract][Full Text] [Related]
2. Revaccination and Adverse Event Recurrence in Patients with Adverse Events following Immunization.
Muñoz CE; MacDonald B; Pham-Huy A; Vaudry W; Pernica JM; Boucher FD; Constantinescu C; Sadarangani M; Bettinger JA; Tapiéro B; Morris SK; McConnell A; Cowan J; Zafack J; Upton J; Abdurrahman Z; McHenry M; Hildebrand KJ; Noya F; De Serres G; Halperin SA; Top KA;
J Pediatr; 2022 Nov; 250():45-53.e3. PubMed ID: 35948192
[TBL] [Abstract][Full Text] [Related]
3. Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study.
Fitzpatrick T; Yamoah P; Lacuesta G; Sadarangani M; Cook V; Pourshahnazari P; Kalicinsky C; Upton JEM; Cameron SB; Zaborniak K; Kanani A; Lam G; Burton C; Constantinescu C; Pernica JM; Abdurrahman Z; Betschel S; Drolet JP; De Serres G; Quach C; Des Roches A; Chapdelaine H; Salvadori MI; Carignan A; McConnell A; Pham-Huy A; Buchan CA; Cowan J; Hildebrand K; Top KA;
Vaccine; 2024 Jun; ():. PubMed ID: 38910092
[TBL] [Abstract][Full Text] [Related]
4. Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
Christou-Ergos M; Wiley KE; Leask J
Vaccine; 2023 Jan; 41(1):246-250. PubMed ID: 36446655
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial.
Nyambayo PPM; Gold MS; Mehta UC; Clarke S; Manyevere R; Chirinda L; Zifamba EN; Nyamandi T
Vaccine; 2023 Oct; 41(45):6700-6709. PubMed ID: 37805357
[TBL] [Abstract][Full Text] [Related]
6. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
[TBL] [Abstract][Full Text] [Related]
7. A scoping review of active, participant-centred, digital adverse events following immunization (AEFI) surveillance: A Canadian immunization research network study.
Psihogios A; Brianne Bota A; Mithani SS; Greyson D; Zhu DT; Fung SG; Wilson SE; Fell DB; Top KA; Bettinger JA; Wilson K
Vaccine; 2022 Jul; 40(31):4065-4080. PubMed ID: 35680501
[TBL] [Abstract][Full Text] [Related]
8. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
[TBL] [Abstract][Full Text] [Related]
9. Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China.
Wang C; Huang N; Lu QB; Black S; Liang X; Cui F
Front Immunol; 2022; 13():956473. PubMed ID: 36248783
[TBL] [Abstract][Full Text] [Related]
10. Adverse events following immunization: real causality and myths.
Principi N; Esposito S
Expert Opin Drug Saf; 2016 Jun; 15(6):825-35. PubMed ID: 26986067
[TBL] [Abstract][Full Text] [Related]
11. Imprecision in vaccine adverse event reporting and a methodological analysis of reporting systems to improve pharmacovigilance and public health.
Inokuma Y; Kneller R
Eur J Clin Pharmacol; 2023 Jul; 79(7):989-1002. PubMed ID: 37249640
[TBL] [Abstract][Full Text] [Related]
12. The characteristics and trend of adverse events following immunization reported by information system in Jiangsu province, China, 2015-2018.
Hu R; Peng S; Liu Y; Tang F; Wang Z; Zhang L; Gao J; Guo H
BMC Public Health; 2021 Jul; 21(1):1338. PubMed ID: 34229643
[TBL] [Abstract][Full Text] [Related]
13. A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study.
Serhan M; Psihogios A; Kabir N; Bota AB; Mithani SS; Smith DP; Zhu DT; Greyson D; Wilson S; Fell D; Top KA; Bettinger JA; Wilson K
Hum Vaccin Immunother; 2024 Dec; 20(1):2293550. PubMed ID: 38374618
[TBL] [Abstract][Full Text] [Related]
14. [Surveillance of adverse events following immunization in Minhang district of Shanghai from 2007 to 2010].
Zhang LP; Yu F; Jin BF; Wang Y; Xu HL; DU Y
Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):859-64. PubMed ID: 23302620
[TBL] [Abstract][Full Text] [Related]
15. [Adverse events following immunization reported with COVID-19 vaccines in Burkina Faso: Analysis of spontaneous reports].
Sawadogo R; Ouoba J; Ilboudo D; Tchoumbi E; Lankoandé-Haro S; Fofana S; Sombié I; Samadoulougou S; Kirakoya-Samadoulougou F
Sante Publique; 2024 Feb; 35(6):149-159. PubMed ID: 38388395
[TBL] [Abstract][Full Text] [Related]
16. Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands.
Kant A; Jansen J; van Balveren L; van Hunsel F
Drug Saf; 2022 Apr; 45(4):319-331. PubMed ID: 35314943
[TBL] [Abstract][Full Text] [Related]
17. Active surveillance of adverse events following immunization (AEFI): a prospective 3-year vaccine safety study.
Sebastian J; Gurumurthy P; Ravi MD; Ramesh M
Ther Adv Vaccines Immunother; 2019; 7():2515135519889000. PubMed ID: 31799496
[TBL] [Abstract][Full Text] [Related]
18. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017.
Masuka JT; Khoza S
BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314
[TBL] [Abstract][Full Text] [Related]
19. Best practice implementation on reporting of coronavirus disease 2019 vaccine adverse events following immunization in Uasin Gishu County, Kenya.
Amdany H; Koech B
JBI Evid Implement; 2023 Jun; 21(2):146-155. PubMed ID: 36545897
[TBL] [Abstract][Full Text] [Related]
20. Adverse Event Following Immunization (AEFI) in Children: An Analysis of Reporting in VigiAccess.
Pandey D; Mehta G; Sachdeva M; Tripathi R
Drug Res (Stuttg); 2022 Oct; 72(8):435-440. PubMed ID: 35724674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
